AGP Executive Report
Last update: a few seconds agoFederal Marijuana Rescheduling: A key Monday deadline (Aug. 17) is set for optional post-hearing briefs in the DEA’s long-running push to move marijuana from Schedule I to Schedule III, with an advisory recommendation expected before any final decision—potentially reshaping the U.S. cannabis market, research, and state programs. Hawaii Hemp Crackdown: Hawaii’s Department of Health is tightening enforcement on hemp-derived THC products sold without medical cards, and an industry lawsuit argues the state is effectively recriminalizing federally legal hemp. Cannabis M&A: Curaleaf’s unsolicited $272M bid for Aurora Cannabis signals consolidation is accelerating, raising the odds of more takeover talk across global medical cannabis. Business & Regulation Watch: A GS1 India CEO says medicine QR codes need stronger standardization across the healthcare supply chain to better fight counterfeits and improve tracking. Drug Enforcement (Nigeria): NDLEA reports major airport and warehouse busts, including 1.55kg cocaine concealed in luggage and large codeine syrup and “Colorado” seizures, as it pushes its anti-trafficking campaign.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
